Why America Can’t Afford To Lose Biotech Leadership To China

China’s biotech sector is surging. For the first time, it now leads the world in clinical trials and new drug licensing. The U.S., once the undisputed leader in pharmaceutical innovation, risks losing its competitive edge unless decisive action is taken.

To safeguard both our economy and national security, the U.S. must make biotechnology a strategic priority: rebuilding domestic capacity, aligning incentives and fostering an…